rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    RMD
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      ResMed CEO Reports Option Exercises and Share Sale

      Tipranks Press Release.

      Nov 13The Globe and MailRMD
      Here's How Much $100 Invested In ResMed 10 Years Ago Would Be Worth Today
      Nov 13BenzingaRMD
      Buy ResMed Stock. It’s a Bargain at This Price.

      ResMed, whose devices treat sleep apnea, has dropped on unfounded concerns that weight-loss drugs will replace its treatment. The stock is cheap and worth buying at current prices.

      Nov 5Barron'sRMD
      ResMed Inc. stock rises Wednesday, outperforms market
      Nov 4MarketWatchRMD
      ResMed: A Quality Compounder, But Not Yet A Bargain (NYSE:RMD)

      ResMed is a Hold, valuation offers a low margin of safety despite strong long-term fundamentals and recurring revenue streams. Read more on RMD stock here.

      Nov 3Seeking AlphaRMD
      ResMed Inc. stock rises Monday, outperforms market
      Nov 2MarketWatchRMD
      ResMed: 3 Key Takeaways for Long-Term Investors
      Nov 2Yahoo FinanceRMD
      What Sent ResMed Stock Lower?
      Nov 2Yahoo FinanceRMD
      ResMed Inc. stock falls Friday, underperforms market
      Oct 30MarketWatchRMD
      ResMed (RMD) Looks Fully Valued After Another Earnings Beat
      Oct 30Yahoo FinanceRMD
      RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin Climbs

      Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

      Oct 30The Globe and MailRMD
      ResMed (RMD) Reports Q1 Earnings: What Key Metrics Have to Say
      Oct 30Yahoo FinanceRMD
      ResMed Inc. Q1 2027 Earnings Call Summary
      Oct 30Yahoo FinanceRMD
      Needham reiterates Hold on ResMed stock amid GLP-1 drug risks
      Oct 30Investing.comRMD
      What ResMed (RMD) Said on Its Q1 Earnings Call
      Oct 30Yahoo FinanceRMD
      Mizuho raises ResMed stock price target to $270 on resupply strength
      Oct 30Investing.comRMD
      ResMed Inc (RMD) Q1 2027 Earnings Call Highlights: Revenue Climbs 7%, EPS Jumps 14%, and Record ...
      Oct 30Yahoo FinanceRMD
      ResMed Q1 FY27 slides: strong margins, $1B shareholder returns
      Oct 29Investing.comRMD
      Earnings call transcript: ResMed tops Q1 2026 estimates as margin expands
      Oct 29Investing.comRMD
      ResMed Q1 2027 Earnings Call Transcript
      Oct 29BenzingaRMD
      ResMed earnings beat by $0.23, revenue topped estimates
      Oct 29Investing.comRMD
      ResMed (NYSE:RMD) posts better-than-expected sales in Q3 CY2026
      Oct 29BarchartRMD
      ResMed (RMD) Beats Q1 Earnings and Revenue Estimates

      ResMed (RMD) delivered earnings and revenue surprises of +8.99% and +1.66%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

      Oct 29Yahoo FinanceRMD
      ResMed Fiscal Q1 Adjusted Earnings, Revenue Rise
      Oct 29Yahoo FinanceRMD
      ResMed: Fiscal Q1 Earnings Snapshot
      Oct 29Yahoo FinanceRMD
      If You Invested $1000 In ResMed Stock 20 Years Ago, You Would Have This Much Today
      Oct 28BenzingaRMD
      All eyes on ResMed earnings as device dominance faces new tests
      Oct 28Investing.comRMD
      Unlocking Q1 Potential of ResMed (RMD): Exploring Wall Street Estimates for Key Metrics
      Oct 28Yahoo FinanceRMD
      ResMed (RMD) Q3 earnings report preview: what to look for
      Oct 28Yahoo FinanceRMD
      ResMed global general counsel sells $102,000 in company stock
      Oct 27Investing.comRMD
      Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?

      ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

      Oct 23Yahoo FinanceRMD
      ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?
      Oct 23Yahoo FinanceRMD
      Learn Why The Bull Case For ResMed (RMD) Could Change Following U.S. Mask Launch
      Oct 23Yahoo FinanceRMD
      ResMed Inc. stock rises Thursday, outperforms market
      Oct 22MarketWatchRMD
      ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
      Oct 22Yahoo FinanceRMD
      ETFs Are Net Sellers of ResMed (RMD) on Oct. 16
      Oct 20Yahoo FinanceRMD
      Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Hold from Citi

      Tipranks Press Release.

      Oct 20The Globe and MailRMD
      ResMed Inc. stock falls Friday, underperforms market
      Oct 16MarketWatchRMD
      ResMed Inc. stock rises Thursday, outperforms market
      Oct 15MarketWatchRMD
      Resmed Smart Comfort: The Best Inventions of 2026: Special Mentions

      Find out why Resmed Smart Comfort earned a special mention on TIME's list of 2026's best inventions.

      Oct 15TimeRMD
      ResMed’s Quarterly Earnings Preview: What You Need to Know
      Oct 15BarchartRMD
      ResMed’s Quarterly Earnings Preview: What You Need to Know
      Oct 14Yahoo FinanceRMD
      Mizuho Adjusts Price Target on ResMed to $240 From $235
      Oct 13Yahoo FinanceRMD
      ResMed Q4 2026 Earnings Call Transcript - ResMed (NYSE:RMD)

      ResMed (NYSE:RMD) reported fourth-quarter financial results on Thursday. The transcript from the company's fourth-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings

      Oct 12BenzingaRMD
      ResMed Inc. stock rises Monday, outperforms market
      Oct 12MarketWatchRMD
      ResMed Inc. stock rises Friday, outperforms market
      Oct 9MarketWatchRMD
      ResMed chairman & CEO Michael Farrell sells $1.1m in shares
      Oct 8Investing.comRMD
      ResMed Inc. stock rises Wednesday, outperforms market
      Oct 7MarketWatchRMD
      ResMed Inc. stock rises Monday, outperforms market
      Oct 5MarketWatchRMD
      ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?

      ResMed currently trades at $218.94 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 15.9% gain during that period.

      Oct 5Yahoo FinanceRMD

      This is the newest page. Registered accounts read further back.